AbbVie Posts Strong Quarter, Raises Guidance

AbbVie Inc ABBV reported mixed results for the third quarter. While EPS topped by a penny, sales revenue fell shy of estimates. The company boosted its adjusted EPS forecast, but this apparently wasn't enough to satisfy investors.

  • Adjusted EPS increases 7 percent to $1.21, beats by a penny.
  • Delivers net revenues of $6.43 billion, misses by $0.13 billion.
  • Adjusted net revenues advanced 8 percent on an operational basis.
  • Boosts adjusted EPS forecast to $4.80-$4.82 versus Street expectations of $4.82.
  • Announces 12 percent dividend increase for 2017 with dividend payable in February.

Chairman and CEO Richard Gonzalez commented, "We delivered another strong quarter, with EPS growth ahead of our expectations. Year-to-date, we've driven strong commercial, operational and R&D execution, and we have advanced our pipeline and other strategic priorities."

Here is the complete press release: https://news.abbvie.com/news/abbvie-reports-third-quarter-2016-financial-results.htm At last check, the stock fell 4 percent to $59.00 in the pre-market session.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!